For many patients with MS, current disease-modifying therapies (DMTs) can provide control of disease activity especially when more aggressive treatment is initiated early in the disease course. The CE-certified supplement, Risk-Benefit Analysis and Personalized Treatment in Multiple Sclerosis: Basing Treatment Goals on the Latest Evidence, provides clinicians with the most up-to-date evidence on current and …
Continue reading “Risk-Benefit Analysis and Personalized Treatment in MS”
Release Date: 6/30/2020 Expiration Date: 6/29/2021 The third edition of the Advances in Multiple Sclerosis Primer provides an educational experience featuring interactive cases and expert faculty commentary on a variety of MS topics. The content contains many recent updates to the second edition, as well as new sections including diagnosis and continuity of care. Click …
Continue reading “Advances in Multiple Sclerosis (AIMS) Primer: Third Edition”
May 16, 2018 from 8:00 pm to 9:00 pm Writing for scientific publication and presentation in MS nursing is essential to disseminate evidence, share innovations with others, provide new information to keep nurses updated, and share finding of outcomes data collection and research studies. Writing is hard work but the process can be simplified by …
Continue reading “Writing for Publication in Multiple Sclerosis: Webinar PART 2”
Release date: February 15, 2018Valid through: February 15, 2020 Earn 1.5 continuing education credits! Description Comorbidity is an area of increasing interest in MS and evidence has suggested comorbidity is associated with diagnostic delays, misinterpretation of relapses, disability progression, health-related quality of life, and progression of lesion burden on magnetic resonance imaging (MRI). In chronic diseases, it …
Continue reading “Comorbidities in Multiple Sclerosis: A Clinical Resource Guide”
Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Apply new information about MS to a comprehensive individualized treatment plan for patients with MS 2) Integrate the team approach into long-term planning in …
Activity Description and Learning Objectives In this case-based activity, experts in the diagnosis and management of multiple sclerosis discuss practical issues related to personalizing care in patients with this disease. Upon completion of this activity, participants will be able to: Employ updated MS phenotype descriptions and other patient-and disease-specific factors when personalizing treatment regimens in …